Enterprise Value
$807.76 M
$0.000.00%
Thu, 06 Feb 2025 21:00:00 GMT
Summary
- As of February 7, 2025, RVNC enterprise value is $807.76 million, unchanged from the previous trading day.
- Over the past year, RVNC enterprise value has dropped by -$30.34 million (-3.62%).
- RVNC enterprise value is now -76.65% below its all-time high of $3.46 billion.
Performance
RVNC Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
RVNC Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | +3.1% | +6.8% | +6.8% |
| 3 m3 months | -13.8% | -25.2% | -25.2% |
| 6 m6 months | +11.6% | +22.2% | +22.1% |
| ytdytd | +8.3% | +19.3% | +19.3% |
| 1 y1 year | -3.6% | -23.0% | -35.4% |
| 5 y5 years | -41.1% | -74.7% | -86.3% |
RVNC Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.5% | $768 M | +5.2% | |
| 3 m | 3-month | $1.02 B | -20.6% | $741 M | +9.1% |
| 6 m | 6-month | $1.10 B | -26.5% | $724 M | +11.6% |
| 1 y | 1-year | $1.10 B | -26.5% | $592 M | +36.5% |
| 3 y | 3-year | $3.46 B | -76.7% | $592 M | +36.5% |
| 5 y | 5-year | $3.46 B | -76.7% | $569 M | +42.0% |
| alltime | all time | $3.46 B | -76.7% | $175 M | +360.6% |
Revance Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $807.76 M(+8.3%) |
| 2024 | $745.86 M(-34.0%) |
| 2023 | $1.13 B(-38.8%) |
| 2022 | $1.85 B(+33.6%) |
| 2021 | $1.38 B(-24.8%) |
| 2020 | $1.84 B(+159.7%) |
| Date | Value |
|---|---|
| 2019 | $708.22 M(+5.5%) |
| 2018 | $671.05 M(-34.5%) |
| 2017 | $1.02 B(+91.5%) |
| 2016 | $534.88 M(-30.8%) |
| 2015 | $773.20 M(+228.7%) |
| 2014 | $235.25 M |
FAQ
- What is Revance Therapeutics enterprise value?
- What is the all time high enterprise value for Revance Therapeutics?
- What is RVNC enterprise value year-to-date change?
- What is Revance Therapeutics enterprise value year-on-year change?
What is Revance Therapeutics enterprise value?
The current enterprise value of RVNC is $807.76 M
What is the all time high enterprise value for Revance Therapeutics?
Revance Therapeutics all-time high enterprise value is $3.46 B
What is RVNC enterprise value year-to-date change?
Revance Therapeutics enterprise value has changed by +$61.89 M (+8.30%) since the beginning of the year
What is Revance Therapeutics enterprise value year-on-year change?
Over the past year, RVNC enterprise value has changed by -$30.34 M (-3.62%)